Small cell lung cancer (SCLC) accounts for about 15% of lung cancer cases and is categorized into limited and extensive stages. Treatment options include radiation, chemotherapy, and immunotherapy ...
Scientists believe that air pollution could be a major cause behind the rise in global lung cancer cases in people that have ...
Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...
According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...
Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways.
A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...
The WVU Cancer Institute is the first provider in the state to offer a new and promising treatment for extensive-stage small ...
The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback